检索结果 - Scappaticci, Frank

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review 由 Rugo, Hope S., Jacobs, Ira, Sharma, Shikhar, Scappaticci, Frank, Paul, Thomas A., Jensen-Pergakes, Kristen, Malouf, Gabriel G.

获取全文 获取全文 获取全文

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer 由 Parikh, Aparna R., Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P., Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef

获取全文 获取全文 获取全文

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM) 由 Hurwitz, Herbert I., Tan, Benjamin R., Reeves, James A., Xiong, Henry, Somer, Brad, Lenz, Heinz‐Josef, Hochster, Howard S., Scappaticci, Frank, Palma, John F., Price, Richard, Lee, John J., Nicholas, Alan, Sommer, Nicolas, Bendell, Johanna

获取全文 获取全文 获取全文

Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Renal Cell Cancer (RCC) after Sunitinib Failure 由 Tannir, Nizar M., Wong, Yu-Ning, Kollmannsberger, Christian K., Ernstoff, Marc S., Perry, David J., Appleman, Leonard J., Posadas, Edwin M., Cho, Daniel, Choueiri, Toni K., Coates, Andrew, Gupta, Neeraj, Pradhan, Rajendra, Qian, Jiang, Chen, Jihong, Scappaticci, Frank A., Ricker, Justin L., Carlson, Dawn M., Michaelson, M. Dror

获取全文 获取全文 获取全文